Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’
Covered by 2 sources
Anthropic acquired the one-person company Mithril to enhance its AI-driven drug discovery efforts, aiming to accelerate drug development and support its goal of reaching a $1.4 trillion valuation in public markets.